SEC Comment Letter for REVLON — Apr 5, 2022
REVLON INC /DE/ (CIK 0000887921)
Date: April 5, 2022 · CIK: 0000887921 · Accession: 0000000000-22-003663
AI Filing Summary & Sentiment
File numbers found in text: 333-264032
Letter
United States securities and exchange commission logo April 5, 2022 Victoria Dolan Chief Financial Officer REVLON INC /DE/ One New York Plaza New York, NY 10004 Re:REVLON INC /DE/ Registration Statement on Form S-3 Filed March 31, 2022 File No. 333-264032 Dear Ms. Dolan: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Michael Davis at 202-551-4385 or Laura Crotty at 202-551-7614 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: John C. Kennedy
Show Raw Text
United States securities and exchange commission logo
April 5, 2022
Victoria Dolan
Chief Financial Officer
REVLON INC /DE/
One New York Plaza
New York, NY 10004
Re:REVLON INC /DE/
Registration Statement on Form S-3
Filed March 31, 2022
File No. 333-264032
Dear Ms. Dolan:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Michael Davis at 202-551-4385 or Laura Crotty at 202-551-7614 with any
questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: John C. Kennedy